| Cardiovascular and renal outcomes with empagliflozin in heart failure M Packer, SD Anker, J Butler, G Filippatos, SJ Pocock, P Carson, ... New England Journal of Medicine 383 (15), 1413-1424, 2020 | 3847 | 2020 |
| Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 2887 | 2021 |
| Randomised trial of low-dose amiodarone in severe congestive heart failure HC Doval, DR Nul, HO Grancelli, SV Perrone, GR Bortman, R Curiel The Lancet 344 (8921), 493-498, 1994 | 1185 | 1994 |
| Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death HC Doval, DR Nul, HO Grancelli, SD Varini, S Soifer, G Corrado, ... Circulation 94 (12), 3198-3203, 1996 | 382 | 1996 |
| Effect of empagliflozin on cardiovascular and renal outcomes in patients with heart failure by baseline diabetes status: results from the EMPEROR-reduced trial SD Anker, J Butler, G Filippatos, MS Khan, N Marx, CSP Lam, S Schnaidt, ... Circulation 143 (4), 337-349, 2021 | 282 | 2021 |
| Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved … SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, ... European journal of heart failure 21 (10), 1279-1287, 2019 | 229 | 2019 |
| Right atrial size and tricuspid regurgitation severity predict mortality or transplantation in primary pulmonary hypertension M Bustamante-Labarta, S Perrone, RL De La Fuente, P Stutzbach, ... Journal of the American Society of Echocardiography 15 (10), 1160-1164, 2002 | 227 | 2002 |
| Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial SD Solomon, AR Rizkala, MP Lefkowitz, VC Shi, JJ Gong, N Anavekar, ... Circulation: Heart Failure 11 (7), e004962, 2018 | 168 | 2018 |
| Heart rate is a marker of amiodarone mortality reduction in severe heart failure DR Nul, HC Doval, HO Grancelli, SD Varini, S Soifer, SV Perrone, ... Journal of the American College of Cardiology 29 (6), 1199-1205, 1997 | 167 | 1997 |
| Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure HC Doval, DR Nul, HO Grancelli, SV Perrone, GR Bortman, R Curiel, ... Lancet 344 (8921), 493-498, 1994 | 161 | 1994 |
| Post-discharge prognosis of patients admitted to hospital for heart failure by world region, and national level of income and income disparity (REPORT-HF): a cohort study J Tromp, S Bamadhaj, JGF Cleland, CE Angermann, U Dahlstrom, ... The Lancet Global Health 8 (3), e411-e422, 2020 | 144 | 2020 |
| Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo … M Metra, E Eichhorn, WT Abraham, J Linseman, M Böhm, R Corbalan, ... European heart journal 30 (24), 3015-3026, 2009 | 139 | 2009 |
| Prior heart failure hospitalization, clinical outcomes, and response to sacubitril/valsartan compared with valsartan in HFpEF M Vaduganathan, BL Claggett, AS Desai, SD Anker, SV Perrone, ... Journal of the American College of Cardiology 75 (3), 245-254, 2020 | 133 | 2020 |
| Evaluation of the effect of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced … M Packer, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, ... European journal of heart failure 21 (10), 1270-1278, 2019 | 131 | 2019 |
| Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas’ heart disease patient AG Schijman, C Vigliano, J Burgos, R Favaloro, S Perrone, R Laguens, ... The Journal of heart and lung transplantation 19 (11), 1114-1117, 2000 | 118 | 2000 |
| Successful pregnancy and vaginal delivery after heart transplantation BR Löwenstein, NW Vain, SV Perrone, DR Wright, FJ Boullón, ... American journal of obstetrics and gynecology 158 (3), 589-590, 1988 | 110 | 1988 |
| Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial SD Anker, J Butler, G Filippatos, M Shahzeb Khan, JP Ferreira, E Bocchi, ... European journal of heart failure 22 (12), 2383-2392, 2020 | 98 | 2020 |
| Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. RP Laguens, PM Meckert, JS Martino, S Perrone, R Favaloro The Journal of heart and lung transplantation: the official publication of …, 1996 | 90 | 1996 |
| Coagulation and fibrinolytic parameters in patients with pulmonary hypertension R Altman, A Scazziota, J Rouvier, E Gurfinkei, R Favaloro, S Perrone, ... Clinical cardiology 19 (7), 549-554, 1996 | 85 | 1996 |
| Detection of transplant coronary artery disease using multidetector computed tomography with adaptative multisegment reconstruction G Sigurdsson, P Carrascosa, MH Yamani, NL Greenberg, S Perrone, ... Journal of the American College of Cardiology 48 (4), 772-778, 2006 | 84 | 2006 |
Gerasimos FilippatosNational and Kapodistrian University of AthensVerified email at med.uoa.gr
